Off-Label

Off-label refers to the use of a medication or medical device for a purpose not approved by regulatory authorities such as the Food and Drug Administration (FDA) or the European Medicines Agency (EMA). While drugs and devices are initially approved for specific indications based on clinical trials and regulatory review, healthcare providers may sometimes prescribe them for alternative uses or patient populations based on their clinical judgment and evidence of efficacy. Off-label use is common in clinical practice and may be appropriate in certain situations where alternative treatments are limited or unavailable. However, it is important for healthcare providers to carefully consider the risks and benefits of off-label prescribing and to communicate transparently with patients about their treatment options and any potential off-label uses.